Subscribe Now Advertise

Categories

search Result

Indian pharma sector poised for 8-10% growth this fiscal: CRISIL

Following a successful year with approximately 10% growth, the outlook is bolstered by easing pricing pressures in the US generics market and improved operating leverage, which is expected to raise operating margins by 70-80 basis points to around 22.5%. Read more

Nearly 2,000 drug manufacturing plants overdue for FDA inspections post-COVID

These overdue inspections affect about 42% of the 4,700 registered drug manufacturing plants that were reviewed by the FDA before May 2019.Read more

Indian pharma exports surge with 8.36% growth in July 2024

The Indian pharmaceutical industry is projected to grow to $65 billion by 2024 and to $130 billion by 2030. Read more

DCGI introduces guidelines for product traceability in pharma supply chain

The introduction of these guidelines is particularly timely, as the Indian pharmaceutical industry has come under scrutiny following reports linking spurious cough syrups from India to children's deaths in Gambia, Cameroon, and Uzbekistan.Read more

CDSCO mandates GMP compliance for sterile equipment manufacturers

This move marks a significant shift, as GMP compliance was previously required only for drug manufacturers.Read more

India’s API industry expected to grow 7-8% in FY25

The operating profit margin (OPM) is forecasted to rise to 12-14%, up from 11-13% in the previous fiscal year.Read more

60 pharma firms enrol under Centre’s scheme to upgrade manufacturing facilities

The scheme gives preference to micro, small and medium enterprises (MSMEs), supporting smaller players achieve high standards.Read more

CDSCO shuts down 36% of drug manufacturing units for failing quality standards

India has around 10,000 pharma manufacturing units, of which nearly 80 per cent are micro-small and medium-scale facilities. Read more

Mandaviya inaugurates 40 facilities to manufacture bulk drugs, medical devices

India has taken a big step towards self-reliance, with the commissioning of 27 new bulk drug facilities and 13 medical device manufacturing plants.Read more

Union Health Ministry enhances Pharma Quality Control with Revised Schedule M rules

Schedule M outlines the Good Manufacturing Practices (GMP) for pharmaceutical products, and the revised version aims to ensure adherence to GMP standards, emphasising the requirements for premises, plant, and equipment related to pharmaceutical production.Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back